{"key":"op_713_ES","page":{"url":"https://ru.bookimed.com/clinics/country=spain/procedure=immunoterapia-pri-rake-grudi/","procedure":{"id":713,"slug":"immunoterapia-pri-rake-grudi","name":"Иммунотерапия при раке груди","name_forms":{"plural":{"status":"missing","reason":"not_collected"},"genitive":{"status":"missing","reason":"not_collected"}},"type":"therapy","grammar_number":{"status":"missing","reason":"not_collected"},"parent_id":"oncology","family_attribute":{"status":"missing","reason":"not_collected"}},"country":{"id":34,"iso":"ES","name":"Испания"},"currency":"USD","data_date":"2026-09-25"},"pages":{"clinics_url":"https://ru.bookimed.com/clinics/country=spain/procedure=immunoterapia-pri-rake-grudi/","cost_url":"https://ru.bookimed.com/clinics/country=spain/procedure=immunoterapia-pri-rake-grudi/cost/","best_url":{"status":"missing","reason":"template not live"}},"price":{"from":2200,"to":28000,"avg":{"status":"missing","reason":"no_offers"},"us":{"from":60000,"to":150000},"uk":{"from":60000,"to":90000},"by_technique":[{"technique":"PD-1 inhibitor with chemotherapy","technique_id":"pd-1-inhibitor","price_from":8000,"currency":"USD","source":"estimate","date":"2026-11-17"},{"technique":"PD-1/PD-L1 inhibitor plus chemotherapy, metastatic","technique_id":"pd-1","price_from":9500,"currency":"USD","source":"estimate","date":"2026-11-17"}],"by_city":[{"city":"Барселона","from":2200},{"city":"Аликанте","from":9000},{"city":"Мадрид","from":14000}],"per_unit":{"status":"missing","reason":"not_collected"},"factors":{"status":"missing","reason":"not_collected"},"tiers":{"status":"missing","reason":"no_offers"},"comparison":[{"country_iso":"UA","from":6500,"to":15000},{"country_iso":"FR","from":14000,"to":30000},{"country_iso":"GB","from":60000,"to":90000},{"country_iso":"US","from":60000,"to":150000},{"country_iso":"IL","from":28000,"to":48000},{"country_iso":"TR","from":8000,"to":16000},{"country_iso":"MX","from":12000,"to":25000},{"country_iso":"DE","from":14000,"to":30000},{"country_iso":"CA","from":28000,"to":65000},{"country_iso":"AE","from":30000,"to":65000},{"country_iso":"TH","from":5900,"to":14000},{"country_iso":"PL","from":6500,"to":13500},{"country_iso":"KR","from":14000,"to":27000},{"country_iso":"CZ","from":9000,"to":20000},{"country_iso":"AT","from":18000,"to":36000},{"country_iso":"IT","from":18000,"to":34000},{"country_iso":"CN","from":14000,"to":36000},{"country_iso":"AU","from":16000,"to":29000},{"country_iso":"IN","from":14000,"to":23000},{"country_iso":"MY","from":14000,"to":30000},{"country_iso":"VN","from":14000,"to":27000},{"country_iso":"BR","from":9000,"to":20000}],"base_country":"US","base_is_fallback":false},"savings":{"pct":96,"variant":">=15%"},"package":{"included":{"status":"missing","reason":"no_offers"},"excluded":{"status":"missing","reason":"no_offers"},"extra_charges":{"status":"missing","reason":"not_collected"}},"clinics":{"count":4,"items":[{"id":6225,"name":"Hospital Ruber Internacional","city":"Madrid","rating":5,"reviews_count":3,"accreditations":["Joint Commission International","International Organization for Standardization"],"rank":1,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":78,"name":"Centro Médico Teknon","city":"Barcelona","rating":4.7,"reviews_count":498,"accreditations":["Joint Commission International","European Foundation for Quality Management","THE IMTJ MEDICAL TRAVEL AWARD WINNER IN 2019","Patient choice in Neurology","Patient choice in Neurosurgery","Patient choice for Epilepsy treatment","World's Best Hospitals 2021 by Newsweek"],"rank":2,"has_procedure":true,"why_ranked":"Led by Dr. Agusti Barnadas Molins, a specialist with 35+ years in breast cancer and over 130 publications. The clinic offers advanced diagnostics like PD-L1 and TMB testing, and provides personalized treatment plans based on tumor genetics.","bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":422,"name":"Hospital HM Nou Delfos","city":"Barcelona","rating":4.6,"reviews_count":5,"accreditations":["European Foundation for Quality Management","Certification according to DIN EN ISO 9001 by TÜV NORD CERT"],"rank":3,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":953,"name":"GenesisCare Clinics","city":"Madrid","rating":{"status":"missing","reason":"not_collected"},"reviews_count":{"status":"missing","reason":"not_collected"},"accreditations":{"status":"missing","reason":"not_collected"},"rank":4,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}}]},"doctors":{"count":5,"languages":{"status":"missing","reason":"not_collected"}},"cities":[{"id":98,"slug":"barselona","name":"Барселона","clinics_count":1,"price_from":2200,"profile":{"city_type":"Mediterranean coastal city in Spain","access":["Barcelona Airport (BCN), 15 km southwest of city center"],"sources":["https://en.wikipedia.org/wiki/Barcelona","https://en.wikipedia.org/wiki/Barcelona–El_Prat_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":441,"slug":"alicante","name":"Аликанте","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":9000,"profile":{"city_type":"Mediterranean port city in Spain","access":["Alicante Airport (ALC), 9 km from the city"],"sources":["https://en.wikipedia.org/wiki/Alicante","https://en.wikipedia.org/wiki/Alicante%E2%80%93Elche_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":346,"slug":"madrid","name":"Мадрид","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":14000,"profile":{"city_type":"Capital and largest city of Spain","access":["Madrid Barajas Airport (MAD), 13 km from Puerta del Sol"],"sources":["https://en.wikipedia.org/wiki/Madrid","https://en.wikipedia.org/wiki/Madrid–Barajas_Airport"],"checked_at":"2026-11-03","status":"ok"}}],"offers":{"active":{"status":"missing","reason":"no_offers"},"active_with_related":{"status":"missing","reason":"no_offers"},"hospital_nights_median":{"status":"missing","reason":"no_offers"},"days_in_country_median":{"status":"missing","reason":"no_offers"},"top_offers":{"status":"missing","reason":"no_offers"},"packages":{"status":"missing","reason":"no_offers"},"related_packages":{"status":"missing","reason":"no_offers"},"other_packages":{"status":"missing","reason":"no_offers"}},"medical":{"indications":["High-risk stage II-III early triple-negative breast cancer, with chemotherapy","Metastatic PD-L1-positive triple-negative breast cancer, with chemotherapy"],"contraindications":["Active autoimmune disease requiring systemic immunosuppression","History of organ transplant","Prior severe immune-related adverse event","Active uncontrolled infection","Pregnancy or breastfeeding","History of interstitial lung disease or pneumonitis","Long-term high-dose corticosteroid use"],"operation_hours":{"min":2,"max":6,"unit":"hours","qualifier":"Per visit; longer when combined with chemotherapy and pre-infusion tests."},"anesthesia":["none"],"sessions_or_stages":{"sessions":{"min":9,"max":17,"unit":"visits","qualifier":"Infusions every 3-6 weeks for about a year, usually with chemotherapy."},"stages":[{"code":"neoadjuvant","label":"Immunotherapy with chemotherapy before surgery","after":{"min":0,"max":168,"unit":"days","qualifier":"About 5.5 months of combined cycles."}},{"code":"surgery","label":"Surgery at home or local center","after":{"min":170,"max":210,"unit":"days","qualifier":"Timing set by treating oncology team."}},{"code":"adjuvant","label":"Adjuvant immunotherapy continuation","after":{"min":220,"max":365,"unit":"days","qualifier":"Continues up to about a year in total."}}],"qualifier":"Typical early high-risk triple-negative protocol; later cycles often continue at home."},"hospital_nights":{"value":{"min":0,"max":0,"unit":"nights","qualifier":"Infusions are given as outpatient visits without overnight stay."},"source":"parsed_details"},"treatment_conditions":["outpatient"],"rehabilitation_days":{"status":"missing","reason":"not_collected"},"fly_home_after_days":{"min":1,"max":3,"unit":"days","qualifier":"Depends on infusion reactions and chemotherapy blood counts."},"back_to_work_days":{"min":2,"max":7,"unit":"days","qualifier":"Fatigue after infusion and concurrent chemotherapy often limit work; many patients work part-time."},"exercise_resume_weeks":{"min":0,"max":1,"unit":"weeks","qualifier":"Light activity as tolerated; intensity depends on fatigue and chemotherapy side effects."},"final_result_months":{"min":6,"max":12,"unit":"months","qualifier":"Response assessed after neoadjuvant phase and surgery; full course lasts about a year."},"result_longevity":"Benefit duration varies; in responders, immune-mediated disease control can persist for years after treatment ends.","main_risks":["Immune-related organ inflammation; some severe or permanent.","Infusion reactions are possible with some agents.","Added toxicity when combined with chemotherapy."],"complication_rate_pct":{"min":60,"max":80,"unit":"percent","qualifier":"Grade 3-4 adverse events including chemotherapy toxicity; immune-related events of grade 3+ about 10-15%."},"revision_rate_pct":{"status":"missing","reason":"not_collected"},"success":{"metric":"Event-free survival at 5 years","value":81,"horizon":"5 years","source":{"status":"missing","reason":"not_collected"},"evidence_status":"proven"},"scars":"None; no incisions.","pain":"Infusion causes only cannula discomfort. Fatigue, joint aches or rash may occur; combined chemotherapy adds further discomfort.","preparation":["Confirm receptor status and PD-L1 result","Baseline blood, liver, thyroid and cortisol tests","Baseline imaging","Review autoimmune and transplant history","Screen for infections such as hepatitis","Pregnancy test if applicable"],"recovery_timeline":[{"phase":"Infusion day","description":"Infusion lasts 30-60 minutes for immunotherapy, longer with chemotherapy; monitored for reactions.","restrictions":["Report fever, breathlessness or rash promptly"]},{"phase":"Days 1-7 after infusion","description":"Fatigue, nausea and mild flu-like symptoms are common, mainly from chemotherapy.","restrictions":["Avoid crowds if blood counts are low"]},{"phase":"Months 1-12","description":"Cycles repeat every 3-6 weeks; immune-related effects may appear at any time, even after completion.","restrictions":["Do not start new medicines without oncologist approval"]}],"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":21,"max":42,"unit":"days","qualifier":"Blood, thyroid and liver tests before each cycle to detect immune-related effects."}},{"purpose":"result_review","requirement":"routine","after":{"min":84,"max":126,"unit":"days","qualifier":"Imaging or response review after several cycles."}},{"purpose":"other","requirement":"conditional","after":{"min":0,"max":7,"unit":"days","qualifier":"Urgent review within days if immune-related side effects suspected."}}],"sources":{"status":"missing","reason":"not_collected"},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check that your breast cancer type is one for which immunotherapy is used, such as triple-negative breast cancer","scope":"procedure","source":{"url":"https://www.cancer.gov/types/breast/patient/breast-treatment-pdq","host":"cancer.gov","quote":"Immunotherapy may be used to treat triple-negative breast cancer.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C2","text":"Check that you and the cancer care team decide the treatment plan together, which may include more than one treatment type","scope":"treatment_type","source":{"url":"https://www.cancer.gov/types/breast/patient/breast-treatment-pdq","host":"cancer.gov","quote":"You and your cancer care team will work together to decide your treatment plan, which may include more than one type of treatment.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C3","text":"Ask how tests will track whether immunotherapy is working, such as tumor size and blood work","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"These tests will measure the size of your tumor and look for changes in your blood work.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C4","text":"Ask which side effects are possible, since immunotherapy can act against healthy cells and tissues in your body","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"Immunotherapy can cause side effects, many of which happen when the immune system that has been revved-up to act against the cancer also acts against healthy cells and tissues in your body.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C5","text":"Check the schedule of regular check-ups during and after treatment","scope":"treatment_type","source":{"url":"https://www.nhs.uk/conditions/breast-cancer/treatment/","host":"nhs.uk","quote":"You'll have regular check-ups during and after any treatments.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C6","text":"Check how to contact the specialists about symptoms or side effects between scheduled check-ups","scope":"treatment_type","source":{"url":"https://www.nhs.uk/conditions/breast-cancer/treatment/","host":"nhs.uk","quote":"If you have any symptoms or side effects that you are worried about, talk to your specialists.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Promise that immunotherapy will produce a result, when only a small portion of patients respond","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"Only a small portion of people who receive immunotherapy will respond to the treatment.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"F2","text":"Offer that does not take your individual preferences into account when choosing the treatment","scope":"treatment_type","source":{"url":"https://www.nice.org.uk/guidance/ng101","host":"nice.org.uk","quote":"It aims to help healthcare professionals offer the right treatments to people, taking into account the person's individual preferences.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"F3","text":"An offer that describes no follow-up check-ups during and after treatment is missing a standard element of care","scope":"treatment_type","source":{"url":"https://www.nhs.uk/conditions/breast-cancer/treatment/","host":"nhs.uk","quote":"You'll have regular check-ups during and after any treatments.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Severe allergic reaction","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/side-effects","host":"cancer.gov","quote":"Some types of immunotherapy may cause severe or fatal allergic and inflammation-related reactions.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W2","text":"Trouble breathing","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/side-effects","host":"cancer.gov","quote":"fever chills weakness dizziness nausea or vomiting muscle or joint aches fatigue headache trouble breathing low or high blood pressure","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W3","text":"Heart palpitations","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/side-effects","host":"cancer.gov","quote":"swelling and weight gain from retaining fluid heart palpitations s inus congestion diarrhea infection organ inflammation","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W4","text":"Fever","urgency":"contact_clinic","general":true,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/side-effects","host":"cancer.gov","quote":"fever chills weakness dizziness nausea or vomiting muscle or joint aches fatigue headache trouble breathing low or high blood pressure","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"Receptor status test","aliases":["Receptor status test","receptor status"],"kind":"lab","origin":[{"field":"preparation","text":"Confirm receptor status and PD-L1 result"},{"field":"initial_assessment_documents","text":"Biopsy pathology report with receptor status"}],"what_it_checks":{"text":"It helps predict whether immunotherapy may work for you","source":{"url":"https://www.cancer.gov/types/breast/treatment/immunotherapy","host":"cancer.gov","quote":"Your doctor may suggest biomarker tests to help predict your response to immunotherapy.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"PD-L1 test","aliases":["PD-L1 test","PD-L1 result","PD-L1 test report","PD-L1"],"kind":"lab","origin":[{"field":"preparation","text":"Confirm receptor status and PD-L1 result"},{"field":"initial_assessment_documents","text":"PD-L1 test report"}],"what_it_checks":{"text":"Checks tumor PD-L1 level to see if immunotherapy may help","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"Your test results will show whether you have enough PD-L1 protein in your tumor for you to benefit from a specific immunotherapy medicine.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":{"text":"You may need to stop certain medicines, such as blood thinners, before the test","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"You may need to stop taking certain medicines, such as blood thinners Â like aspirin, before this test.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}},{"id":"T3","name":"Blood tests","aliases":["Blood tests","Baseline blood tests","Recent blood tests"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood, liver, thyroid and cortisol tests"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and thyroid function"}],"what_it_checks":{"text":"Looks for changes in blood work during immunotherapy","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"These tests will measure the size of your tumor and look for changes in your blood work.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T4","name":"Liver function test","aliases":["Liver function test","liver tests","liver function","LFT"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood, liver, thyroid and cortisol tests"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and thyroid function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T5","name":"Thyroid function test","aliases":["Thyroid function test","thyroid tests","thyroid function","TFT"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood, liver, thyroid and cortisol tests"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and thyroid function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"Cortisol test","aliases":["Cortisol test","cortisol tests","cortisol"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood, liver, thyroid and cortisol tests"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T7","name":"Hepatitis screening test","aliases":["Hepatitis screening test","hepatitis","HBV","HCV"],"kind":"lab","origin":[{"field":"preparation","text":"Screen for infections such as hepatitis"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T8","name":"Pregnancy test","aliases":["Pregnancy test","hCG"],"kind":"lab","origin":[{"field":"preparation","text":"Pregnancy test if applicable"}],"what_it_checks":{"text":"Flags a fetus at risk, since immunotherapy is usually avoided","source":{"url":"https://www.cancer.gov/types/breast/breast-cancer-during-pregnancy","host":"cancer.gov","quote":"Hormone therapy, targeted therapy, and immunotherapy are usually not given to pregnant or nursing women because these treatments are harmful to a fetus or a nursing baby.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T9","name":"PET-CT scan","aliases":["PET-CT scan","PET-CT"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent PET-CT or CT scan reports"}],"what_it_checks":{"text":"Stages breast cancer; may be dangerous for a developing fetus","source":{"url":"https://www.cancer.gov/types/breast/breast-cancer-during-pregnancy","host":"cancer.gov","quote":"Some tests, such as CT or PET-CT scans that are used to stage breast cancer in women who aren't pregnant, may be dangerous for a developing fetus or a nursing baby due to radiation or use of dyes or radioactive tracers.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T10","name":"CT scan","aliases":["CT scan","CT","CT scan reports"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent PET-CT or CT scan reports"}],"what_it_checks":{"text":"Stages breast cancer; may be dangerous for a developing fetus","source":{"url":"https://www.cancer.gov/types/breast/breast-cancer-during-pregnancy","host":"cancer.gov","quote":"Some tests, such as CT or PET-CT scans that are used to stage breast cancer in women who aren't pregnant, may be dangerous for a developing fetus or a nursing baby due to radiation or use of dyes or radioactive tracers.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"prep_in_advance":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"},"visit_and_day":{"status":"ok","has_procedure_day":true,"items":[{"id":"V1","text":"Immunotherapy may be given in a doctor's office, a clinic, or an outpatient unit in a hospital","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"You may receive immunotherapy in a doctor’s office, clinic, or outpatient unit in a hospital.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V2","text":"Outpatient treatment means the patient does not stay overnight in the hospital","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"Outpatient means you do not spend the night in the hospital.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V3","text":"Immunotherapy treatment may be scheduled every day, every week, or every month","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"You may have treatment every day, week, or month.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V4","text":"The doctor checks the patient often with physical exams and asks how the patient feels","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"He or she will give you physical exams and ask you how you feel.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"}},"parsed_details":{"procedure_type":"therapy","fields":{"anesthesia":["none"],"back_to_work_days":{"min":2,"max":7,"unit":"days","qualifier":"Fatigue after infusion and concurrent chemotherapy often limit work; many patients work part-time."},"complication_rate_pct":{"min":60,"max":80,"unit":"percent","qualifier":"Grade 3-4 adverse events including chemotherapy toxicity; immune-related events of grade 3+ about 10-15%."},"contraindications":["Active autoimmune disease requiring systemic immunosuppression","History of organ transplant","Prior severe immune-related adverse event","Active uncontrolled infection","Pregnancy or breastfeeding","History of interstitial lung disease or pneumonitis","Long-term high-dose corticosteroid use"],"days_in_clinic":{"min":0,"max":0,"unit":"nights","qualifier":"Infusions are given as outpatient visits without overnight stay."},"diagnostic_duration_minutes":null,"diagnostic_preparation":null,"diagnostic_referral_needed":null,"diagnostic_result_time_hours":null,"exercise_resume_weeks":{"min":0,"max":1,"unit":"weeks","qualifier":"Light activity as tolerated; intensity depends on fatigue and chemotherapy side effects."},"final_result_months":{"min":6,"max":12,"unit":"months","qualifier":"Response assessed after neoadjuvant phase and surgery; full course lasts about a year."},"fly_home_after_days":{"min":1,"max":3,"unit":"days","qualifier":"Depends on infusion reactions and chemotherapy blood counts."},"follow_up_visits":[{"purpose":"assessment","after":{"min":21,"max":42,"unit":"days","qualifier":"Blood, thyroid and liver tests before each cycle to detect immune-related effects."},"requirement":"routine"},{"purpose":"result_review","after":{"min":84,"max":126,"unit":"days","qualifier":"Imaging or response review after several cycles."},"requirement":"routine"},{"purpose":"other","after":{"min":0,"max":7,"unit":"days","qualifier":"Urgent review within days if immune-related side effects suspected."},"requirement":"conditional"}],"indications":["High-risk stage II-III early triple-negative breast cancer, with chemotherapy","Metastatic PD-L1-positive triple-negative breast cancer, with chemotherapy"],"main_risks":["Immune-related organ inflammation; some severe or permanent.","Infusion reactions are possible with some agents.","Added toxicity when combined with chemotherapy."],"pain":"Infusion causes only cannula discomfort. Fatigue, joint aches or rash may occur; combined chemotherapy adds further discomfort.","preparation":["Confirm receptor status and PD-L1 result","Baseline blood, liver, thyroid and cortisol tests","Baseline imaging","Review autoimmune and transplant history","Screen for infections such as hepatitis","Pregnancy test if applicable"],"recovery_timeline":[{"phase":"Infusion day","description":"Infusion lasts 30-60 minutes for immunotherapy, longer with chemotherapy; monitored for reactions.","restrictions":["Report fever, breathlessness or rash promptly"]},{"phase":"Days 1-7 after infusion","description":"Fatigue, nausea and mild flu-like symptoms are common, mainly from chemotherapy.","restrictions":["Avoid crowds if blood counts are low"]},{"phase":"Months 1-12","description":"Cycles repeat every 3-6 weeks; immune-related effects may appear at any time, even after completion.","restrictions":["Do not start new medicines without oncologist approval"]}],"rehabilitation_days":null,"result_longevity":"Benefit duration varies; in responders, immune-mediated disease control can persist for years after treatment ends.","revision_rate_pct":null,"scars":"None; no incisions.","sessions_or_stages":{"sessions":{"min":9,"max":17,"unit":"visits","qualifier":"Infusions every 3-6 weeks for about a year, usually with chemotherapy."},"stages":[{"code":"neoadjuvant","label":"Immunotherapy with chemotherapy before surgery","after":{"min":0,"max":168,"unit":"days","qualifier":"About 5.5 months of combined cycles."}},{"code":"surgery","label":"Surgery at home or local center","after":{"min":170,"max":210,"unit":"days","qualifier":"Timing set by treating oncology team."}},{"code":"adjuvant","label":"Adjuvant immunotherapy continuation","after":{"min":220,"max":365,"unit":"days","qualifier":"Continues up to about a year in total."}}],"qualifier":"Typical early high-risk triple-negative protocol; later cycles often continue at home."},"success":{"metric":"Event-free survival at 5 years","value":81,"unit":"percent","horizon":"5 years","population":"Early high-risk triple-negative breast cancer treated with PD-1 inhibitor plus chemotherapy","evidence_status":"proven"},"techniques":[{"name":"PD-1 inhibitor with chemotherapy","suits_whom":"Early high-risk triple-negative breast cancer","recovery":"Outpatient infusions every 3 weeks; fatigue for days."},{"name":"PD-1/PD-L1 inhibitor plus chemotherapy, metastatic","suits_whom":"PD-L1-positive metastatic triple-negative breast cancer","recovery":"Outpatient infusions every 3-4 weeks until progression."}],"treatment_conditions":["outpatient"],"treatment_duration_hours":{"min":2,"max":6,"unit":"hours","qualifier":"Per visit; longer when combined with chemotherapy and pre-infusion tests."},"initial_assessment_documents":["Biopsy pathology report with receptor status","PD-L1 test report","Recent PET-CT or CT scan reports","Prior chemotherapy and surgery summary","Recent blood tests with liver and thyroid function","Record of autoimmune disease or transplant"],"travel_trips":{"min":4,"max":8,"one_trip_possible":false,"qualifier":"Neoadjuvant phase: one infusion per trip, 3-5 days; some cycles can be given at home."},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check that your breast cancer type is one for which immunotherapy is used, such as triple-negative breast cancer","scope":"procedure","source":{"url":"https://www.cancer.gov/types/breast/patient/breast-treatment-pdq","host":"cancer.gov","quote":"Immunotherapy may be used to treat triple-negative breast cancer.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C2","text":"Check that you and the cancer care team decide the treatment plan together, which may include more than one treatment type","scope":"treatment_type","source":{"url":"https://www.cancer.gov/types/breast/patient/breast-treatment-pdq","host":"cancer.gov","quote":"You and your cancer care team will work together to decide your treatment plan, which may include more than one type of treatment.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C3","text":"Ask how tests will track whether immunotherapy is working, such as tumor size and blood work","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"These tests will measure the size of your tumor and look for changes in your blood work.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C4","text":"Ask which side effects are possible, since immunotherapy can act against healthy cells and tissues in your body","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"Immunotherapy can cause side effects, many of which happen when the immune system that has been revved-up to act against the cancer also acts against healthy cells and tissues in your body.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C5","text":"Check the schedule of regular check-ups during and after treatment","scope":"treatment_type","source":{"url":"https://www.nhs.uk/conditions/breast-cancer/treatment/","host":"nhs.uk","quote":"You'll have regular check-ups during and after any treatments.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C6","text":"Check how to contact the specialists about symptoms or side effects between scheduled check-ups","scope":"treatment_type","source":{"url":"https://www.nhs.uk/conditions/breast-cancer/treatment/","host":"nhs.uk","quote":"If you have any symptoms or side effects that you are worried about, talk to your specialists.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Promise that immunotherapy will produce a result, when only a small portion of patients respond","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"Only a small portion of people who receive immunotherapy will respond to the treatment.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"F2","text":"Offer that does not take your individual preferences into account when choosing the treatment","scope":"treatment_type","source":{"url":"https://www.nice.org.uk/guidance/ng101","host":"nice.org.uk","quote":"It aims to help healthcare professionals offer the right treatments to people, taking into account the person's individual preferences.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"F3","text":"An offer that describes no follow-up check-ups during and after treatment is missing a standard element of care","scope":"treatment_type","source":{"url":"https://www.nhs.uk/conditions/breast-cancer/treatment/","host":"nhs.uk","quote":"You'll have regular check-ups during and after any treatments.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Severe allergic reaction","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/side-effects","host":"cancer.gov","quote":"Some types of immunotherapy may cause severe or fatal allergic and inflammation-related reactions.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W2","text":"Trouble breathing","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/side-effects","host":"cancer.gov","quote":"fever chills weakness dizziness nausea or vomiting muscle or joint aches fatigue headache trouble breathing low or high blood pressure","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W3","text":"Heart palpitations","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/side-effects","host":"cancer.gov","quote":"swelling and weight gain from retaining fluid heart palpitations s inus congestion diarrhea infection organ inflammation","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W4","text":"Fever","urgency":"contact_clinic","general":true,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/side-effects","host":"cancer.gov","quote":"fever chills weakness dizziness nausea or vomiting muscle or joint aches fatigue headache trouble breathing low or high blood pressure","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"alternatives":{"status":"ok","items":[{"id":"A1","text":"You need a treatment that reaches cancer cells throughout the body","name":"Chemotherapy","source":{"url":"https://www.cancer.gov/types/breast/treatment","host":"cancer.gov","quote":"Systemic treatments , such as chemotherapy, are drugs that can reach cancer cells throughout the body.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200},"operation_id":37},{"id":"A2","text":"Your treatment needs to target the area with cancer","name":"Radiation therapy","source":{"url":"https://www.cancer.gov/types/breast/treatment","host":"cancer.gov","quote":"Local treatments , such as surgery and radiation, are directed at the area with cancer and not the whole body.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200},"operation_id":null}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"technique_details":{"status":"ok","items":[{"id":"pd-1-inhibitor","name":"PD-1 inhibitor with chemotherapy","how_it_works":{"text":"Immunotherapy is given with chemotherapy before surgery to shrink the tumor","source":{"url":"https://www.cancer.gov/types/breast/treatment/immunotherapy","host":"cancer.gov","quote":"You might get it with chemotherapy before surgery to help shrink the tumor so that it can be removed more easily during surgery.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"pd-1","name":"PD-1/PD-L1 inhibitor plus chemotherapy, metastatic","how_it_works":{"text":"Immunotherapy may be combined with chemotherapy for metastatic or recurrent breast cancer","source":{"url":"https://www.cancer.gov/types/breast/treatment/immunotherapy","host":"cancer.gov","quote":"Immunotherapy may also be given with chemotherapy for metastatic breast cancer or recurrent breast cancer that cannot be removed by surgery.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"Receptor status test","aliases":["Receptor status test","receptor status"],"kind":"lab","origin":[{"field":"preparation","text":"Confirm receptor status and PD-L1 result"},{"field":"initial_assessment_documents","text":"Biopsy pathology report with receptor status"}],"what_it_checks":{"text":"It helps predict whether immunotherapy may work for you","source":{"url":"https://www.cancer.gov/types/breast/treatment/immunotherapy","host":"cancer.gov","quote":"Your doctor may suggest biomarker tests to help predict your response to immunotherapy.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"PD-L1 test","aliases":["PD-L1 test","PD-L1 result","PD-L1 test report","PD-L1"],"kind":"lab","origin":[{"field":"preparation","text":"Confirm receptor status and PD-L1 result"},{"field":"initial_assessment_documents","text":"PD-L1 test report"}],"what_it_checks":{"text":"Checks tumor PD-L1 level to see if immunotherapy may help","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"Your test results will show whether you have enough PD-L1 protein in your tumor for you to benefit from a specific immunotherapy medicine.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":{"text":"You may need to stop certain medicines, such as blood thinners, before the test","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"You may need to stop taking certain medicines, such as blood thinners Â like aspirin, before this test.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}},{"id":"T3","name":"Blood tests","aliases":["Blood tests","Baseline blood tests","Recent blood tests"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood, liver, thyroid and cortisol tests"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and thyroid function"}],"what_it_checks":{"text":"Looks for changes in blood work during immunotherapy","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"These tests will measure the size of your tumor and look for changes in your blood work.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T4","name":"Liver function test","aliases":["Liver function test","liver tests","liver function","LFT"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood, liver, thyroid and cortisol tests"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and thyroid function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T5","name":"Thyroid function test","aliases":["Thyroid function test","thyroid tests","thyroid function","TFT"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood, liver, thyroid and cortisol tests"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and thyroid function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"Cortisol test","aliases":["Cortisol test","cortisol tests","cortisol"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood, liver, thyroid and cortisol tests"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T7","name":"Hepatitis screening test","aliases":["Hepatitis screening test","hepatitis","HBV","HCV"],"kind":"lab","origin":[{"field":"preparation","text":"Screen for infections such as hepatitis"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T8","name":"Pregnancy test","aliases":["Pregnancy test","hCG"],"kind":"lab","origin":[{"field":"preparation","text":"Pregnancy test if applicable"}],"what_it_checks":{"text":"Flags a fetus at risk, since immunotherapy is usually avoided","source":{"url":"https://www.cancer.gov/types/breast/breast-cancer-during-pregnancy","host":"cancer.gov","quote":"Hormone therapy, targeted therapy, and immunotherapy are usually not given to pregnant or nursing women because these treatments are harmful to a fetus or a nursing baby.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T9","name":"PET-CT scan","aliases":["PET-CT scan","PET-CT"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent PET-CT or CT scan reports"}],"what_it_checks":{"text":"Stages breast cancer; may be dangerous for a developing fetus","source":{"url":"https://www.cancer.gov/types/breast/breast-cancer-during-pregnancy","host":"cancer.gov","quote":"Some tests, such as CT or PET-CT scans that are used to stage breast cancer in women who aren't pregnant, may be dangerous for a developing fetus or a nursing baby due to radiation or use of dyes or radioactive tracers.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T10","name":"CT scan","aliases":["CT scan","CT","CT scan reports"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent PET-CT or CT scan reports"}],"what_it_checks":{"text":"Stages breast cancer; may be dangerous for a developing fetus","source":{"url":"https://www.cancer.gov/types/breast/breast-cancer-during-pregnancy","host":"cancer.gov","quote":"Some tests, such as CT or PET-CT scans that are used to stage breast cancer in women who aren't pregnant, may be dangerous for a developing fetus or a nursing baby due to radiation or use of dyes or radioactive tracers.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"prep_in_advance":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"},"visit_and_day":{"status":"ok","has_procedure_day":true,"items":[{"id":"V1","text":"Immunotherapy may be given in a doctor's office, a clinic, or an outpatient unit in a hospital","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"You may receive immunotherapy in a doctor’s office, clinic, or outpatient unit in a hospital.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V2","text":"Outpatient treatment means the patient does not stay overnight in the hospital","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"Outpatient means you do not spend the night in the hospital.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V3","text":"Immunotherapy treatment may be scheduled every day, every week, or every month","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"You may have treatment every day, week, or month.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V4","text":"The doctor checks the patient often with physical exams and asks how the patient feels","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"He or she will give you physical exams and ask you how you feel.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"}}},"techniques":[{"id":"pd-1-inhibitor","name":"PD-1 inhibitor with chemotherapy","how_it_works":{"id":"H1","text":"Immunotherapy is given with chemotherapy before surgery to shrink the tumor","source":{"url":"https://www.cancer.gov/types/breast/treatment/immunotherapy","host":"cancer.gov","quote":"You might get it with chemotherapy before surgery to help shrink the tumor so that it can be removed more easily during surgery.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Early high-risk triple-negative breast cancer","price_from":8000,"recovery":"Outpatient infusions every 3 weeks; fatigue for days."},{"id":"pd-1","name":"PD-1/PD-L1 inhibitor plus chemotherapy, metastatic","how_it_works":{"id":"H1","text":"Immunotherapy may be combined with chemotherapy for metastatic or recurrent breast cancer","source":{"url":"https://www.cancer.gov/types/breast/treatment/immunotherapy","host":"cancer.gov","quote":"Immunotherapy may also be given with chemotherapy for metastatic breast cancer or recurrent breast cancer that cannot be removed by surgery.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"PD-L1-positive metastatic triple-negative breast cancer","price_from":9500,"recovery":"Outpatient infusions every 3-4 weeks until progression."}],"alternatives":{"status":"ok","items":[{"id":"A1","text":"You need a treatment that reaches cancer cells throughout the body","name":"Chemotherapy","source":{"url":"https://www.cancer.gov/types/breast/treatment","host":"cancer.gov","quote":"Systemic treatments , such as chemotherapy, are drugs that can reach cancer cells throughout the body.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200},"operation_id":37},{"id":"A2","text":"Your treatment needs to target the area with cancer","name":"Radiation therapy","source":{"url":"https://www.cancer.gov/types/breast/treatment","host":"cancer.gov","quote":"Local treatments , such as surgery and radiation, are directed at the area with cancer and not the whole body.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200},"operation_id":null}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"diagnostic":{"status":"not_applicable"},"country":{"why":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-11","next_check_at":"2027-02-09"},"travel":{"status":"ok","items":[{"id":"V1","item":"passport_validity","audience":"uk","volatile":true,"text":"The passport must have an expiry date at least 3 months after you plan to leave the Schengen area","source":{"url":"https://www.gov.uk/foreign-travel-advice/spain/entry-requirements","host":"gov.uk","quote":"have an ‘expiry date’ at least 3 months after the day you plan to leave the Schengen area (the expiry date does not need to be within 10 years of the date of issue)","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V2","item":"medicines","audience":"all","volatile":false,"text":"Carry prescription medication in its original packaging, along with your doctor's prescription","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Spain.html","host":"travel.state.gov","quote":"Always carry your prescription medication in original packaging, along with your doctor’s prescription.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V3","item":"prescriptions","audience":"us","volatile":false,"text":"Medications that require a prescription in the United States also require a local doctor's prescription in Spain","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Spain.html","host":"travel.state.gov","quote":"Medications requiring prescriptions in the United States also require a local doctor’s prescription in Spain.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V4","item":"ghic","audience":"uk","volatile":false,"text":"A GHIC or EHIC is needed to get medically necessary state healthcare in Spain","source":{"url":"https://www.gov.uk/foreign-travel-advice/spain/health","host":"gov.uk","quote":"To get medically necessary state healthcare in Spain, you need a Global Health Insurance Card ( GHIC ) or a European Health Insurance Card ( EHIC ).","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V5","item":"hospital_payment","audience":"all","volatile":false,"text":"Private hospitals usually require payment or proof of insurance or funds before admitting a patient","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Spain.html","host":"travel.state.gov","quote":"Private hospitals usually require payment or proof insurance or funds before admitting a patient.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V6","item":"emergency_number","audience":"all","volatile":false,"text":"Dial 112 and ask for an ambulance","source":{"url":"https://www.gov.uk/foreign-travel-advice/spain/health","host":"gov.uk","quote":"Dial 112 and ask for an ambulance.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2026-12-11","version":1},"other_countries_with_page":["austria","azerbaijan","china","germany","greece","india","israel","italy","latvia","malaysia","mexico","republic-of-korea","switzerland","thailand","turkey","ukraine"]},"often_combined_with":{"status":"missing","reason":"not_collected"},"reviews":{"avg_rating":4.7,"count":506,"scope":"clinic","rating_scale":5,"pros":{"status":"missing","reason":"not_collected"},"cons":{"status":"missing","reason":"not_collected"}},"current":{"seo_text":"<p>Immunotherapy for breast cancer in Spain generally costs from _op_713_price_from_ to _op_713_price_to_. The final price depends on the specific drug protocol, such as pembrolizumab, and the number of cycles required. In the US, this procedure costs _price_compare_US_average_ on average. Private hospital quotes typically include medication, oncologist consultations, infusion administration, and routine monitoring.</p>\n\n<ul>\n<li><strong>Drug type.</strong> Protocols using checkpoint inhibitors like Keytruda often cost more than standard monotherapy.</li>\n<li><strong>Cycle frequency.</strong> Total expenditure increases with the number of infusions needed for advanced staging.</li>\n<li><strong>Diagnostics.</strong> Specialized tests like PD-L1 biomarker status and PET-CT scans are typically billed separately.</li>\n<li><strong>Medical hubs.</strong> Major treatment centers are primarily located in Barcelona and Madrid.</li>\n</ul>\n\n<p><strong>Bookimed Expert Insight.</strong> Spain is a global leader in clinical trials for triple-negative breast cancer. Specialists like Dr. Javier Cortes Castan at Centro Médico Teknon have led pivotal trials for pembrolizumab. Patients often find high value at JCI-accredited facilities like Hospital Ruber Internacional. These centers offer technologies like Da Vinci Xi and CyberKnife. General oncology price ranges in Barcelona often start around $2,150. Even top-tier specialists at EFQM-accredited Hospital HM Nou Delfos provide access to innovative targeted therapies.</p>","faq":[{"q":"What types of breast cancer can be treated with immunotherapy in Spain?","a":"<p>Spanish hospitals primarily use immunotherapy to treat high-risk triple-negative breast cancer (TNBC) and HER2-positive metastatic disease. Leading oncology centers like Centro Medico Teknon utilize Pembrolizumab (Keytruda) for early-stage neoadjuvant care and Margetuximab-cmkb for advanced HER2-positive cases guided by PD-L1 biomarker testing.</p> <ul> <li><strong>Triple-negative (TNBC):</strong> Pembrolizumab is standard for high-risk early-stage and PD-L1 positive metastatic cases.</li> <li><strong>Neoadjuvant protocol:</strong> Specialists use combination chemotherapy plus immunotherapy to shrink tumors before surgical intervention.</li> <li><strong>HER2-positive cases:</strong> Antibody-drug conjugates like Margetuximab-cmkb treat metastatic disease after other targeted therapies.</li> <li><strong>High-risk luminal:</strong> Patients with hormone-positive cancers and extremely high Ki67 levels may qualify.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Spanish oncology centers like Hospital HM Nou Delfos often integrate immunotherapy into neoadjuvant protocols rather than just late-stage care. While the US average for immunotherapy is _price_compare_US_average_, specialized protocols in Spain range from _op_713_price_from_ to _op_713_price_to_. This investment often includes the Keynote-522 trial standards which prioritize aggressive early treatment to reduce recurrence risks.</p> <p><strong>Patient Consensus:</strong> Patients with triple-negative diagnoses frequently emphasize the importance of starting the Keynote-522 protocol immediately. Many find comfort in the precision biomarker testing standard in Barcelona and Madrid hospitals.</p>"},{"q":"Which immunotherapy drugs are approved for breast cancer in Spain?","a":"<p>Pembrolizumab (Keytruda) is the primary immunotherapy drug approved in Spain for triple-negative breast cancer. It is sanctioned by the European Medicines Agency (EMA) for high-risk early-stage and metastatic cases. Sacituzumab govitecan (Trodelvy) is also used for advanced metastatic patients in Spanish oncology centers.</p> <ul> <li><strong>Early-stage TNBC:</strong> Used with chemotherapy as neoadjuvant and adjuvant treatment per Keynote-522 protocol.</li> <li><strong>Metastatic TNBC:</strong> Pembrolizumab is approved for PD-L1 positive tumors (CPS score &ge; 10).</li> <li><strong>Maintenance schedule:</strong> Patients typically receive maintenance immunotherapy every 3 weeks following initial combination chemo.</li> <li><strong>Regulatory oversight:</strong> All therapies require approval from the Spanish Agency for Medicines (AEMPS).</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Spain ranks 3 in our global oncology requests due to its precision medicine focus. Leading experts like Dr. Joan Albanell Mestres at Hospital HM Nou Delfos specialize in specific neoadjuvant protocols. These protocols typically involve 3 months of combined treatment before switching to maintenance phases.</p> <p><strong>Patient Consensus:</strong> Patients emphasize asking your oncologist specifically about the Keynote-522 protocol. Many found that this combined approach significantly improved their pathological complete response rates.</p>"},{"q":"Who are the leading specialists for breast cancer immunotherapy in Spain?","a":"<p>Leading breast cancer immunotherapy specialists in Spain include Dr. Agusti Barnadas Molins at Centro Médico Teknon and Dr. Joan Albanell Mestres at Hospital HM Nou Delfos. These experts lead research groups like GEICAM, focusing on systemic treatments for triple-negative and HER2-positive cancer subtypes.</p> <ul> <li><strong>Dr. Agusti Barnadas Molins:</strong> Specialist with 35 years experience and founder of the GEICAM research group.</li> <li><strong>Dr. Aleix Prat:</strong> President of SOLTI board and head of program at Hospital Quiron Barcelona.</li> <li><strong>Dr. Joan Albanell Mestres:</strong> Oncology lead at Hospital HM Nou Delfos specializing in targeted systemic therapies.</li> <li><strong>Hospital accreditations:</strong> Facilities like Centro Médico Teknon hold Joint Commission International and Newsweek rankings.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While Madrid hosts top-tier facilities like Hospital Ruber Internacional, Barcelona remains the primary hub for clinical trials. Surgeons here often hold patents for molecular subtyping. Choosing a Barcelona-based specialist provides direct access to these cutting-edge early-phase research protocols.</p> <p><strong>Patient Consensus:</strong> Patients emphasize the importance of verifying treatment plans with multidisciplinary tumor boards. Many highlight that leading centers strictly follow international NCCN guidelines for complex triple-negative cases.</p>"},{"q":"How does immunotherapy work for breast cancer?","a":"<p>Immunotherapy for breast cancer strengthens the immune system to identify and eliminate malignant cells. It primarily targets the PD-1/PD-L1 pathway, removing molecular brakes that prevent T-cells from attacking tumors. This approach is standard for high-risk, early-stage triple-negative breast cancer in JCI-accredited Spanish centers.</p> <ul> <li><strong>Systemic mechanism:</strong> Blocks PD-1 proteins to help immune cells recognize and destroy cancer cells effectively.</li> <li><strong>Standard protocol:</strong> Utilizes Keynote 522 protocol combining Keytruda (pembrolizumab) with chemotherapy for triple-negative cases.</li> <li><strong>Treatment duration:</strong> Requires 1 year of therapy, though experts may discuss 6-month de-escalation options.</li> <li><strong>Clinical administration:</strong> Injected intravenously every 3 to 6 weeks at specialized medical oncology departments.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Spain has become a hub for immunotherapy due to its participation in over 70 concurrent clinical trials led by experts like Dr. Agusti Barnadas Molins. Patients often choose Barcelona because centers like Centro Médico Teknon integrate genomic profiling with PD-L1 testing. This helps determine if a tumor is likely to respond before starting the expensive 1-year protocol.</p> <p><strong>Patient Consensus:</strong> Patients report that treatment is generally more manageable than traditional chemotherapy alone, focusing on fatigue and skin rashes. Many emphasize the importance of early testing, as approximately 20% of triple-negative patients see transformative, long-term results.</p>"},{"q":"What are the common side effects of immunotherapy?","a":"<p>Common side effects of immunotherapy include fatigue, skin rashes, and joint pain, typically peaking 1–2 weeks after infusion. While reactions are often milder than chemotherapy, they can cause immune-related inflammation in the lungs, liver, or endocrine system, sometimes appearing up to 2 years post-treatment.</p> <ul> <li><strong>Fatigue patterns:</strong> Tiredness peaks 1–2 weeks post-infusion, generally lasting 5 to 7 days.</li> <li><strong>Endocrine health:</strong> Regular TSH testing is required to monitor for potentially lifelong thyroid dysfunction.</li> <li><strong>Dermatological reactions:</strong> Mild rashes or skin pigment changes may surface up to 17 days later.</li> <li><strong>Inflammatory response:</strong> Patients often notice swelling in hands, feet, or head shortly after treatment.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Spain ranks 3rd globally for oncology requests on our platform, largely due to high-volume centers like Hospital HM Nou Delfos. Data shows that while immunotherapy is an outpatient procedure, the long-term monitoring for endocrine issues is critical. Leading Spanish oncologists like Dr. Agusti Barnadas Molins emphasize that side effects can be delayed; patients should maintain vigilance for adrenal or thyroid changes for 24 months after their final cycle.</p> <p><strong>Patient Consensus:</strong> Patients frequently highlight the importance of distinguishing immunotherapy fatigue from standard tiredness. Many report that monitoring for cold intolerance or rapid weight gain was vital for catching early thyroid issues.</p>"},{"q":"Are there ongoing clinical trials for immunotherapy in Spain?","a":"<p>Spain is a leading global hub for immunotherapy clinical trials. It authorized over 900 trials in 2022. Oncology research occupies one-third of these studies. Major centers in Madrid and Barcelona actively test novel molecules, CAR T-cell therapies, and mRNA-based treatments alongside standard protocols.</p> <ul> <li><strong>Research volume:</strong> Spain ranks among the top 4 European countries for clinical trial participation.</li> <li><strong>Specialized centers:</strong> Facilities like Centro Médico Teknon and MD Anderson lead advanced oncological research.</li> <li><strong>Active studies:</strong> Current trials include Leronlimab for triple-negative breast cancer and various Phase I molecules.</li> <li><strong>Expert oversight:</strong> Specialists like Dr. Agusti Barnadas Molins oversee over 70 research projects annually.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While many seek trials for `new` drugs, Spain’s real strength lies in precision oncology. Leading doctors like Dr. Aleix Prat hold multiple patents for gene expression research. This expertise allows clinics to match patients with specific trials based on molecular subtypes. Most high-volume centers in Barcelona and Madrid leverage these insights to offer targeted immunotherapy options that general hospitals might overlook.</p> <p><strong>Patient Consensus:</strong> Patients emphasize that Pembrolizumab combined with chemotherapy is now the standard for triple-negative breast cancer. Many recommend using international registries to track specific Spanish trial sites for emerging therapies like Leronlimab.</p>"}],"h2":[{"text":"Как это работает","kind":"content"},{"text":"Какая цена иммунотерапии при раке груди в Испании?","kind":"content"},{"text":"Лучшие клиники по иммунотерапии при раке груди в Испании — 4 проверенных варианта с ценами","kind":"content"},{"text":"Обзор процедуры Иммунотерапия при раке груди в Испании","kind":"content"},{"text":"Получите медицинскую консультацию по иммунотерапии при раке груди в Испании: Выбирайте среди лучших специалистов в этой области","kind":"content"},{"text":"Видеоистории пациентов Bookimed","kind":"content"},{"text":"Отзывы о Bookimed: узнайте о реальном опыте пациентов","kind":"content"},{"text":"Поделитесь этим материалом","kind":"content"},{"text":"FAQ по иммунотерапии при раке груди в Испании","kind":"content"},{"text":"Получить бесплатную консультацию","kind":"content"}]},"placeholders":{"price_from":"{{price_from}}","clinics_count":"{{clinics_count}}","cities_count":"{{cities_count}}","savings_pct":"{{savings_pct}}","data_date":"{{data_date}}"},"legal":{"restricted_markets":{"status":"missing","reason":"not_collected"}},"conflicts":[]}